- PMLiVE

Assessing the impact of rarity on French HTA and pricing decisions

With changes to the pricing and access processes such as the new Accord Cadre and the soon-to-be implemented ATU reform likely to impact pricing and access of orphan products in...

- PMLiVE

Creative destruction

Biotech’s problems create opportunities for others

- PMLiVE

Addressing the diversity issue in clinical trials

How patient-centric analytics can be used to design more diverse, inclusive and equitable trials

- PMLiVE

Pharma’s vital role in sustainability and corporate social responsibility

Pharma is in the spotlight as tough questions about sustainability commitments continue to arise

- PMLiVE

Influenza – the risk to vulnerable populations

Why we can't get complacent about flu vaccination

- PMLiVE

Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk

The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors

- PMLiVE

Concerns about data security are building a strong case for clinical mobility in EMEA

Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?

- PMLiVE

Developing a portfolio strategy

Approaches to portfolio strategy have become more holistic across the healthcare industry, but what are the benefits for business?

- PMLiVE

The role of digital health technology tools in supporting medical adherence

How DHT-based digital interventions can help to support patients and improve adherence

- PMLiVE

Global leaders in digital channels

Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement

- PMLiVE

We’ve got talent

By Mike Dixon

- PMLiVE

C-Suite keystones

By Brian D Smith